BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.00005 par value
Symbol
BCLI on OTC
Shares outstanding
7,182,182
Price per share
$0.58
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,317
Total reported value
$1,727
Share change
-233,437
Value change
-$261,340
Number of holders
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% +100% $652,925 +$380,336 717,500 +140% Armistice Capital, LLC 31 Mar 2025

As of 30 Sep 2025, 5 institutional investors reported holding 2,317 shares of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI). This represents 0.03% of the company’s total 7,182,182 outstanding shares.

Institutional Holders of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$188 $0.58 0
2025 Q3 2,317 $1,727 -$261,340 $0.71 5
2025 Q2 235,778 $263,958 -$804,996 $1.12 33
2025 Q1 866,024 $1,091,190 +$799,421 $1.26 31
2024 Q4 206,710 $468,811 +$407,283 $2.27 29
2024 Q3 157,266 $36,709 +$36,712 $0.23 4